Show simple item record

dc.identifier.urihttp://hdl.handle.net/1951/56083
dc.identifier.urihttp://hdl.handle.net/11401/71775
dc.description.sponsorshipThis work is sponsored by the Stony Brook University Graduate School in compliance with the requirements for completion of degree.en_US
dc.formatMonograph
dc.format.mediumElectronic Resourceen_US
dc.language.isoen_US
dc.publisherThe Graduate School, Stony Brook University: Stony Brook, NY.
dc.typeThesis
dcterms.abstractCancer is the second major cause of death in the United States and is the leading cause of death of patients below the age of 85. Traditional chemotherapeutics, such as paclitaxel (Taxol ¶©) and docetaxel (Taxotere ¶©) have had a significant impact in the field of chemotherapy because of their unique mechanism of action of inducing apoptosis by stabilizing microtubules during mitotic cell division. However, studies have indicated that these drugs are not active in multi-drug resistant (MDR) cancer cells. MDR arises from the overexpression of ATP-binding cassette proteins which enable the cancer cell to remove cytotoxic agents from the cell via ATP dependent efflux pumps, resulting in the loss of efficacy of the drug. In addition to the problem of MDR, traditional chemotherapeutics have little or no specificity, which leads to systemic toxicity, causing severe and harmful side effects. Therefore, it is important to develop next generation taxoids with increased potency and activity in MDR expressing cancers, as well as to incorporate these cytotoxic agents to tumor-targeting delivery systems to ensure selective cytotoxicity and reduce systemic toxicity. In general, these delivery systems include a tumor-targeting module (TTM) and a cytotoxic agent. Highly potent next generation taxanes, SB-T-1214, SB-T-121602, and SB-T-121302, were synthesized via Ojima-Holton coupling protocol using enantiopure Beta-lactam and modified 10-Deacetyl-Baccatin III (10-DAB). The Beta-lactam required for the Ojima-Holton coupling protocol was afforded via two synthetic routes; Staudinger [2+2] cycloaddition followed by enzymatic resolution protocol and by the chiral ester enolate-imine cyclocondensation. In addition, tumor-targeting drug conjugates were synthesized using linolenic acid (LNA) as the tumor-targeting module. LNA is an essential fatty acid which plays a crucial role in many metabolic processes. Polyunsaturated fatty acids, such as LNA, are greedily taken up by tumor cells as biochemical precursors, making them effective tumor-targeting agents. Several LNA drug conjugates were synthesized, including LNA-SB-T-1214 and LNA-SB-T-121602 as well as a tumor targeting drug conjugate that incorporates a methyl-branched disulfide linker.
dcterms.available2012-05-17T12:21:49Z
dcterms.available2015-04-24T14:49:07Z
dcterms.contributorIwao Ojima.en_US
dcterms.contributorIsaac Carricoen_US
dcterms.contributorDale Drueckhammer.en_US
dcterms.creatorParasram, Melvin
dcterms.dateAccepted2012-05-17T12:21:49Z
dcterms.dateAccepted2015-04-24T14:49:07Z
dcterms.dateSubmitted2012-05-17T12:21:49Z
dcterms.dateSubmitted2015-04-24T14:49:07Z
dcterms.descriptionDepartment of Chemistryen_US
dcterms.formatMonograph
dcterms.formatApplication/PDFen_US
dcterms.identifierParasram_grad.sunysb_0771M_10557.pdfen_US
dcterms.identifierhttp://hdl.handle.net/1951/56083
dcterms.identifierhttp://hdl.handle.net/11401/71775
dcterms.issued2011-05-01
dcterms.languageen_US
dcterms.provenanceMade available in DSpace on 2012-05-17T12:21:49Z (GMT). No. of bitstreams: 1 Parasram_grad.sunysb_0771M_10557.pdf: 4191387 bytes, checksum: eeb01d31cb3bbe004d27666c840422c4 (MD5) Previous issue date: 1en
dcterms.provenanceMade available in DSpace on 2015-04-24T14:49:07Z (GMT). No. of bitstreams: 3 Parasram_grad.sunysb_0771M_10557.pdf.jpg: 1894 bytes, checksum: a6009c46e6ec8251b348085684cba80d (MD5) Parasram_grad.sunysb_0771M_10557.pdf: 4191387 bytes, checksum: eeb01d31cb3bbe004d27666c840422c4 (MD5) Parasram_grad.sunysb_0771M_10557.pdf.txt: 201152 bytes, checksum: 16c9d1d72cbe3ceabed14d43b0ee64d4 (MD5) Previous issue date: 1en
dcterms.publisherThe Graduate School, Stony Brook University: Stony Brook, NY.
dcterms.subjectChemistry -- Oncology
dcterms.subjectBeta-Lactam, Cancer, Ojima-Holton Coupling, Paclitaxel, Polyunsaturated Fatty Acids, Tumor-targeting modules
dcterms.titleSynthesis of Next Generation Taxanes and Tumor-Targeting Taxane-Based Drug Conjugates using Linolenic Acid as Tumor-Targeting Module
dcterms.typeThesis


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record